The Drug Enforcement Administration (DEA) and Department of Health and Human Services (HHS) released their second temporary rule extending pandemic-related telehealth flexibilities.
Anthony Fanucci, Sofia Molodanof, and Sean Sullivan discuss the new temporary rule, why the DEA and HHS decided to extend guidance, and how long you can expect the flexibility for prescribing controlled medications via telemedicine to continue.
Subscribe to Our Health Care Updates >
View More Healthy Bytes > | Return to Digital Transformation of Health Care >